Other factors that may increase infection risk in diabetes patients include: Immunosuppressive effects of poorly controlled hyperglycemia Neuropathy leading to reduced sensation and delayed recognition of infections Vascular complications impairing tissue perfusion and immune cell delivery Frequent antibiotic use for other infections, disrupting normal flora Obesity , which is common in type 2 diabetes and creates skin folds prone to moisture and fungal growth Conversely, medications that improve glycemic control, including GLP-1 receptor agonists and tirzepatide, generally reduce infection risk by normalizing the metabolic environment
Using VA healthcare records, we emulated a randomized trial following more than 333,000 adults with type 2 diabetes for up to three years, testing 16 different treatment scenarios continuous use, discontinuation at various time points, interruption, and restart, Al-Aly said
On the 2025-2030 Cliff
Role of IGF1R in breast cancer subtypes, stemness, and lineage differentiation
A higher signal may be related to more living cells, higher metabolism per cell, or both
We currently offer a range of ready-to-use products targeting GCGR, including recombinant ECD proteins, synthetic nanodisc full-length multi-transmembrane proteins, biosimilar reference antibodies, and biotin-labeled antibodies
